Evidence map›Paper›PMID 34261435›Full record

SynthesisThe journal of headache and pain2021

Comorbidities of primary headache disorders: a literature review with meta-analysis.

Valeria Caponnetto, Manuela Deodato, Micaela Robotti, Maria Koutsokera, Valeria Pozzilli, Cristina Galati, Giovanna Nocera, Eleonora De Matteis, Gioacchino De Vanna, Emanuela Fellini and 8 more

Registry-linked trialOpen access · goldAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in The journal of headache and pain, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06957873 (Evaluation of the Relationship Between Craniovertebral Angle and Fibromyalgia Symptom Severity), which is not on this map. Cited by 113 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 6 pooled it
20.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06957873 recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of the Relationship Between Craniovertebral Angle and Fibromyalgia Symptom Severity

TypeobservationalSponsorAnkara Training and Research HospitalRan2025 to 2026Enrolled134ConditionsCraniovertebral Angle, Fibromyalgia Syndrome
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 6 syntheses or guidelines pooled it, 198 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Psychological interventions for migraine.Nature reviews. Neurology · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Commented on by
    2022
5 · Who and what money

Authors and funding

18 authors at 11 institutions in 3 countries.

Valeria Caponnetto *SS Filippo & Nicola Hospital , University of L'Aquila, Avezzano, Italy. valeria.caponnetto@univaq.it.
Manuela Deodato *Department of Life Sciences, University of Trieste, Trieste, Italy. mdeodato@units.it.
Micaela RobottiCentro di Diagnosi e Cura delle Cefalee, Palazzo della Salute, Gruppo San Donato, Milano, Italy.
Maria KoutsokeraThriassio General Hospital of Elefsina, Elefsina, Greece.
Valeria PozzilliInternal Medicine Unit, Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Cristina GalatiUO Neuropsichiatria Infantile, Policlinico Universitario Paolo Giaccone, Università degli Studi di Palermo, Palermo, Italy.
Giovanna NoceraUO Neuropsichiatria Infantile, Policlinico Universitario Paolo Giaccone, Università degli Studi di Palermo, Palermo, Italy.
Eleonora De MatteisNeuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, L'Aquila, Italy.
Gioacchino De VannaClinica Neurologica, Dipartimento di Medicina, Università degli Studi di Perugia, Perugia, Italy.
Emanuela FelliniInternal Medicine Unit, Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Gleni HaliliDepartment of Neurology, University Hospital Center 'Mother Teresa', Tirana, Albania.
Daniele MartinelliDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Gabriele NalliInternal Medicine Unit, Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Serena SerratoreInternal Medicine Unit, Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Irene TramacereDipartimento di Ricerca e Sviluppo Clinico, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Paolo Martelletti *Department of Clinical and Molecular Medicine, Sapienza University, Roma, Italy.
Alberto Raggi *UOC Neurologia, Salute Pubblica, Disabilità, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.ORCID http://orcid.org/0000-0002-7433-7779
European Headache Federation School of Advanced Studies (EHF-SAS)
Sapienza University of Rome · ITAzienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITUniversity of L'Aquila · ITCentro Clinico Nemo · ITCTO Andrea Alesini · ITMother Teresa Hospital · ALThriasio General Hospital of Elefsina · GRUniversity of Pavia · ITUniversity of Perugia · ITUniversity of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary headache disorders are common and burdensome conditions. They are associated to several comorbidities, such as cardiovascular or psychiatric ones, which, in turn, contribute to the global burden of headache. The aim of this study is to provide a comprehensive description of the pooled prevalence of comorbidities of primary headache disorders using a meta-analytical approach based on studies published between 2000 and 2020.

methodsScopus was searched for primary research (clinical and population studies) in which medical comorbidities were described in adults with primary headache disorders. Comorbidities were extracted using a taxonomy derived from the Global Burden of Disease (GBD) study. We compared prevalence of comorbidities among headache sufferers against general population using GBD-2019 estimates, and compared comorbidities' proportions in clinical vs. population studies, and by age and gender.

resultsA total of 139 studies reporting information on 4.19 million subjects with primary headaches were included: in total 2.75 million comorbidities were reported (median per subject 0.64, interquartile range 0.32-1.07). The most frequently addressed comorbidities were: depressive disorders, addressed in 51 studies (pooled proportion 23 %, 95 % CI 20-26 %); hypertension, addressed in 48 studies (pooled proportion 24 %, 95 % CI 22-26 %); anxiety disorders addressed in 40 studies (pooled proportion 25 %, 95 % CI 22-28 %). For conditions such as anxiety, depression and back pain, prevalence among headache sufferers was higher than in GBD-2109 estimates. Associations with average age and female prevalence within studies showed that hypertension was more frequent in studies with higher age and less females, whereas fibromyalgia, restless leg syndrome, and depressive disorders were more frequent in studies with younger age and more female.

conclusionsSome of the most relevant comorbidities of primary headache disorders - back pain, anxiety and depression, diabetes, ischemic heart disease and stroke - are among the most burdensome conditions, together with headache themselves, according to the GBD study. A joint treatment of headaches and of these comorbidities may positively impact on headache sufferers' health status and contribute to reduce the impact of a group of highly burdensome diseases.

Indexed as

Headache DisordersHeadache Disorders, PrimaryAdultAnxietyAnxiety DisordersComorbidityCross-Sectional StudiesFemaleHumansPrevalenceCHComorbidityDepressionDiabetesHypertensionMigraineObesityPrimary headacheSleep disordersStrokeTTH

Identifiers

PMID34261435
PMCPMC8278743
OpenAlexW3181574304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.